Kynuramine dihydrobromide
Kynuramine dihydrobromide, an endogenously occurring amine, is a fluorescent substrate of plasma amine oxidase.
For research use only. We do not sell to patients.
- CAS No.: 304-47-2
- Formula: C9H14Br2N2O
- Molecular Weight:326.03
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Kynuramine dihydrobromide inhibits both presynaptic and postsynaptic α-adrenoceptors in vitro[2].
Kynuramine dihydrobromide has been shown to act as a partial agonist on serotonin receptors in dog cerebral arteries[2].
Kynuramine dihydrobromide (20 μg/mL) causes a small contraction of the ileum but failed to alter the twitch response to cholinergic stimulation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Kynuramine dihydrobromide (1.25-5.0 mg/kg; i.v.; single does) increases heart rate and blood pressure in rats[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female rats[3].
-
Dosage:0.064, 0.32, 1.6 or 8 μg.
-
Administration:Intraventricular injection; single does.
-
Result:Produced facilitation of lordosis behavior.
-
Animal Model:Male rats (about 200g)[4].
-
Dosage:1.25, 2.5 and 5.0 mg/kg.
-
Administration:Intravenous injection; single does.
-
Result:Promoted heart rate and blood pressure.
Chemical Information
-
CAS No. 304-47-2
-
Molecular Weight 326.03
-
Formula C9H14Br2N2O
-
SMILES
O=C(C1=CC=CC=C1N)CCN.[H]Br.[H]Br
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. J B Massey, et al. Kynuramine, a fluorescent substrate and probe of plasma amine oxidase. J Biol Chem. 1977 Nov 25;252(22):8081-4. [Content Brief]
[2]. T D Johnson, An alpha-adrenoceptor inhibitory action of kynuramine. Eur J Pharmacol. 1981 Jul 10;72(4):351-6. [Content Brief]
[3]. S D Mendelson, et al. Intraventricular administration of l-kynurenine and kynuramine facilitates lordosis in the female rat. Eur J Pharmacol. 1987 Oct 27;142(3):447-51. [Content Brief]
[4]. T D Johnson, et al. Blood pressure and heart rate effects of kynuramine in pithed rats. Eur J Pharmacol. 1983 Feb 18;87(2-3):323-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz